Cognitive function

Potential for CBD to treat traumatic brain injuries, review concludes

Potential for CBD to treat traumatic brain injuries, review concludes

By Olivia Brown

Cannabidiol (CBD) shows strong potential for its inclusion in clinical treatment of traumatic brain injuries (TBI), with mechanisms of action including the mediation of the cellular and biochemical changes associated with the injuries, a recent literature...

5 take-aways we learned during our Business Leaders Forum

5 take-aways we learned during our Business Leaders Forum

By Stephen Daniells

From 2022 sales numbers to consumer enthusiasm remaining high, and from progress with equality and diversity in the industry to the growth in awareness around the importance of the microbiome for health, there were lots of talking points from our 3rd...

© Jacob Wackerhausen / Getty Images

The emerging opportunity for microbiome modulation to improve sleep

By Stephen Daniells

Consumers are increasingly aware of the detrimental effects of not getting enough sleep, and emerging links between the gut microbiota and sleep present opportunities for pre-, pro-, and postbiotics in the booming natural sleep aid category.

BioActor acquisition brings new product potential for Solabia

BioActor acquisition brings new product potential for Solabia

By Olivia Brown

Solabia looks set to grow their current active ingredient range after obtaining a majority stake in BioActor, a leading innovator in extracted polyphenol production from fruits and plants with clinically proven health benefits.

7 Reasons to Enter the NutraIngredients Awards!

7 Reasons to Enter the NutraIngredients Awards!

By Stephen Daniells

The 2023 NutraIngredients Awards are back with new categories but the same commitment to honour the best and brightest in ingredients, finished products, companies, people, and initiatives in food supplements and functional food & beverage.

© ed chechine / Getty Images

Guest Article: Issues and challenges for omega-3s in 2022

By Ellen Schutt, Executive Director, GOED

While 2022 may be categorized as the year the world returned to somewhat normalcy, the last 12 months still held their share of challenges, and for omega-3s, questions remain about how the market will change in 2023.

Getty | Andrew Brookes

Study findings: "The good, the bad and the ugly"

By Nikki Hancocks

There is "room for the improvement" of design, analysis and reporting of nutrition studies, researchers have concluded following a meta-epidemiological analysis of more than 2,000 studies.